Mechanisms of escaping cellular senescence

Radiation Oncology Investigations

Volumn 3, Issue 6, 1995, Pages 284-289

  Shay, Jerry W ^a   Wright, Woodring E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

aging; immortalization; p53; pRB; telomerase; telomeres

Indexed keywords

EID: 0013592260     PISSN: 10657541     EISSN: 15206823     Source Type: Journal    
DOI: 10.1002/roi.2970030607     Document Type: Article

References (72)

1. Reversible cellular senescence: Implications for immortalization of normal human diploid fibroblasts
2. The two‐stage mechanism controlling senescence and immortalization
3. Quantitation of the frequency of immortalization of normal diploid fibroblasts by SV40 large T‐antigen
4. Defining the molecular mechanisms of human cell immortalization
5. Progress of aging in human diploid cells transformed with a tsA mutant of simian virus 40
6. Transformation of human cells by temperature‐sensitive mutants of simian virus 40
7. Adenovirus E1b‐58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells
8. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA
9. SV40‐transformed human fibroblasts: Evidence for cellular aging in precrisis cells
10. A role for both Rb and p53 in the regulation of human cellular senescence
11. Reexpression of senescent markers in de‐induced reversibly immortalized cells
12. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts
13. The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T‐antigen
14. Enhanced degradation of p53 protein in HPV‐6 and BPV‐1 E6‐immortalized human mammary epithelial cells
15. Loss of p53 protein in human papillomavirus type 16‐immortalized human mammary epithelial cells
16. his)
17. Soft tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome
18. A cancer family syndrome in twenty‐four kindreds
19. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
20. Germline mutations of the p53 tumor‐suppressor gene in children and young adults with second malignant neoplasms
21. Spontaneous abnormalities in normal fibroblasts from patients with Li‐Fraumeni cancer syndrome: Aneuploidy and immortalization
22. Spontaneous in vitro immortalization of breast epithelial cells from a Li‐Fraumeni patient
23. Cooperative effect of antisense‐Rb and antisense‐p53 oligomers on the extension of life span in human diploid fibroblasts, TIG‐1
24. Telomere loss: Mitotic clock or genetic time bomb?
25. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
26. Telomere end‐replication problem and cell aging
27. Telomere positional effects and the regulation of cellular senescence
28. RAP1 and telomere structure regulate telomere position effects in Saccharomyces cerevisiae
29. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts
30. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity
31. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
32. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats
33. Specific association of human telomerase activity with immortal cells and cancer
34. Telomerase activity in human ovarian carcinoma
35. Telomerase activity in vivo in human malignant hematopoietic cells
36. Telomeres, telomerase, and immortality
37. Is telomerase a universal cancer target?
38. Telomeres and telomerase in human cancer
39. Activation of telomerase in a human tumor
40. Correlating telomerase activity levels with human neuroblastoma outcomes
41. Telomerase activity in gastric cancer
42. Telomerase activity in small‐cell and nonsmall‐cell lung cancers
43. Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepatocellular carcinomas
44. Telomerase activity associated with acquisition of malignancy in human colorectal cancer
45. Cell immortality, telomerase and cancer
46. Telomerase activity in normal leukocytes and in hematologic malignancies
47. Telomerase activity in normal and malignant hematopoietic cells
48. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells
49. Telomeres shorten during ageing of human fibroblasts
50. Telomere reduction in human colorectal carcinoma and with ageing
51. Structure and variability of human chromosome ends
52. Telomeres, telomerase and senescence
53. The telomere hypothesis of cellular aging
54. Telomeres and aging: Fact, fancy, and the future
55. Telomeres and telomerase in aging and cancer
56. Telomere length predicts replicative capacity of human fibroblasts
57. Loss of telomeric DNA during aging may predispose cells to cancer
58. Telomere shortening may contribute to aging and cancer: A perspective
59. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP)
60. Modification of a telomeric repeat amplification protocol (TRAP) results in increased reliability, linearity and sensitivity
61. Time, telomeres and tumours: Is cellular senescence more than an anticancer mechanism?
62. You haven't heard the end of it: Telomere loss may link human aging and cancer
63. Transformation of diploid human fibroblasts by transfection with the V‐sis, PDGF2/C‐sis or T24H‐ras genes
64. Towards an understanding of the malignant transformation of diploid human fibroblasts
65. Resistance of human cells to oncogenic transformation. Cancer cells
66. Resistance of human cells to tumorigenesis induced by cloned transforming genes
67. Developmental and tissue specific regulation of mouse telomerase and telomere length
68. Culture conditions induce the appearance of immortalized C2H mouse cell lines
69. Spontaneous immortalization rate of cultured Chinese hamster cells
70. Implications of the reorganization of the cell genome for aging or immortalization of dividing cells in vitro
71. Establishment of mouse embryo cell in vitro. Relationship of DNA synthesis, senescence and malignant transformation